Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Renal cell carcinoma miRNA molecular marker and application thereof

A technology for molecular markers and renal cell carcinoma, applied in the field of miRNA molecular markers for renal cell carcinoma

Active Publication Date: 2021-04-13
GENERAL HOSPITAL OF NUCLEAR IND
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, which miRNAs can be used as RCC metastasis and prognosis markers still needs further study

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Renal cell carcinoma miRNA molecular marker and application thereof
  • Renal cell carcinoma miRNA molecular marker and application thereof
  • Renal cell carcinoma miRNA molecular marker and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0040] Embodiment 1. prepares the test kit (50 times of reaction) of predicting RCC patient's transfer and prognosis

[0041] 1. Trizol: 50ml;

[0042] 2. Chloroform: 20ml;

[0043] 3. Isopropanol: 30ml;

[0044] 4.75% ethanol; 60ml;

[0045] 5. DEPC water: 10ml;

[0046] 6. miRNA reverse transcription specific primer (its sequence is shown in SEQ NO: 1-4): 100ul;

[0047] 7. 200U / ul M-MLV reverse transcriptase: 50ul;

[0048] 8. SYBR qPCR Mix: 500ul;

[0049] 9. 10uM target gene-specific primer (its sequence is shown in SEQ NO:5-10): each 100ul;

[0050] 10. 10uM internal reference gene U6-specific primer (its sequence is shown in SEQ NO: 11-12): 100ul each.

Embodiment 2

[0051] Example 2. Detection and analysis of miRNA molecular markers in tissue samples

[0052] 1. Collect the RCC tissues to be tested, normal paracancerous tissues, and distantly metastatic RCC tissues, wash them with normal saline, and freeze them in liquid nitrogen.

[0053] 2. Tissue RNA extraction: Add liquid nitrogen into the mortar, cut the tissue into pieces and grind it in liquid nitrogen, take 100mg of tissue and add it to 1ml Trizol, and mix well. Leave it at room temperature for 5 minutes, add 200uL / tube of chloroform, shake vigorously and mix for 15 seconds. Centrifuge at 12,000 rpm for 15 minutes. Carefully pipette the upper aqueous phase into a new Ep tube, add an equal volume of isopropanol, invert and mix well, place at room temperature for 5 minutes, and centrifuge at 12,000 rpm for 10 minutes. Carefully discard the supernatant, add 75% ethanol, mix well and centrifuge at 8000 rpm for 8 minutes. Remove the supernatant, and add DEPC water to dissolve the RN...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a renal cell carcinoma miRNA molecular marker which is used as a metastasis marker and is used for diagnosing and / or evaluating prognosis and metastasis risks of renal cell carcinoma, or as a specific molecular target of the renal cell carcinoma which is applied to treatment of the renal cell carcinoma; wherein the miRNA molecular marker comprises one or more of miR-328, miR-502 and miR-504. By detecting the expression level of miR-328, miR-502 and / or miR-504 in the tissue of a renal cell carcinoma patient, whether the renal cell carcinoma patient has metastasis or not and prognosis can be judged, and the accuracy rate reaches 95% or above. Therefore, by detecting miR-328, miR-502 and / or miR-504 and other molecular biomarkers in the tissue of the renal cell carcinoma patient, the disease progression, metastasis and prognosis of the renal cell carcinoma patient can be evaluated, related treatment can be carried out on symptoms in time, the survival time and quality of life of the patient are improved, and great economic value and social benefits are achieved.

Description

technical field [0001] The invention relates to the technical field of biomedicine, more specifically, it relates to renal cell carcinoma miRNA molecular markers and applications thereof. Background technique [0002] Renal cell carcinoma (RCC) is a common cancer worldwide, accounting for about 2-3% of adult malignancies. In 2017, approximately 63,990 new cases of RCC and more than 14,400 kidney cancer-related deaths were reported in the United States. In China, the incidence of RCC is on the rise. In 2014, there were approximately 68,300 new RCC cases and 25,600 RCC-related deaths. Metastatic dissemination is the most important factor affecting the prognosis of RCC. The 5-year survival rate of patients with primary metastases is about 10%, and the 5-year survival rate of patients with non-metastatic and advanced metastases is 70% to 90%. When first diagnosed, nearly 60% of patients were localized cancer, and 20% were distant metastases. The metastatic spread of RCC main...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12Q1/6886C12N15/11A61K45/00A61P35/00
CPCC12Q1/6886A61K45/00A61P35/00C12Q2600/178C12Q2600/158C12Q2600/118
Inventor 曹志飞张永胜涂健杨天宇钮慧沈珊珊
Owner GENERAL HOSPITAL OF NUCLEAR IND
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com